SCM
TLSIW icon

Shaolin Capital Management’s TriSalus Life Sciences Warrant TLSIW Stock Holding History

Shaolin Capital Management’s Portfolio TLSIW Stock Details TLSIW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-77,164
Closed -$3K – 616
2023
Q2 		$3K Buy
+77,164
New +$5.24K ﹤0.01% 619

Other funds holding TLSIW

MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
ETH
Exos TFP Holdings New York $162M AUM 16.08% 1-Year Est. Return
VI
Vestcor Inc Fredericton, New Brunswick, Canada $3.63B AUM 21.49% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
BCL
Bracebridge Capital LLC Boston, Massachusetts $3.73B AUM 33.02% 1-Year Est. Return

Shaolin Capital Management's TLSIW Position: Q4 2023 in Review

Shaolin Capital Management sold out of TriSalus Life Sciences Warrant (TLSIW) in Q4 2023, closing a stake of 77,164 shares — an estimated $29K sold.

Shaolin Capital Management first reported a position in TLSIW in Q1 2021 and held it in 10 quarters. The position peaked at $93K in Q1 2021. 22 funds tracked by Wall St. Rank hold TLSIW as of Q4 2023.

  • Shaolin Capital Management reported no remaining TriSalus Life Sciences Warrant position as of Q4 2023 after selling out during the quarter.
  • Shaolin Capital Management sold 77,164 TriSalus Life Sciences Warrant shares in Q4 2023, an estimated $29K.
  • Shaolin Capital Management first reported a position in TriSalus Life Sciences Warrant in Q1 2021 and held it in 10 quarters.
  • Shaolin Capital Management's TriSalus Life Sciences Warrant position peaked at $93K in Q1 2021.
  • 22 funds tracked by Wall St. Rank held TriSalus Life Sciences Warrant as of Q4 2023.

Based on Shaolin Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.